List of CoDa Therapeutics patents

Patents where

Current Assignee

Name

‌

CoDa Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7098190 Formulations comprising antisense nucleotides to connexins	Patent 7098190 was granted and assigned to CoDa Therapeutics on August, 2006 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	7098190	August 29, 2006
‌ US Patent 7879811 Formulations comprising antisense nucleotides to connexins	Patent 7879811 was granted and assigned to CoDa Therapeutics on February, 2011 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	7879811	February 1, 2011
‌ US Patent 7919474 Formulations comprising antisense nucleotides to connexins	Patent 7919474 was granted and assigned to CoDa Therapeutics on April, 2011 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	7919474	April 5, 2011
‌ US Patent 8247384 Methods and compositions for wound healing	Patent 8247384 was granted and assigned to CoDa Therapeutics on August, 2012 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	8247384	August 21, 2012
‌ US Patent 9561311 Medical devices	Patent 9561311 was granted and assigned to CoDa Therapeutics on February, 2017 by the United States Patent and Trademark Office.	‌ CoDa Therapeutics	‌ CoDa Therapeutics	United States Patent and Trademark Office	9561311	February 7, 2017
‌ US Patent 9937197 Wound healing compositions and treatments	Patent 9937197 was granted and assigned to CoDa Therapeutics on April, 2018 by the United States Patent and Trademark Office.	‌ CoDa Therapeutics	‌ CoDa Therapeutics	United States Patent and Trademark Office	9937197	April 10, 2018
‌ US Patent 9029339 Impaired wound healing compositions and methods	Patent 9029339 was granted and assigned to CoDa Therapeutics on May, 2015 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	9029339	May 12, 2015
‌ US Patent 9738892 Treatment of fibrotic conditions	Patent 9738892 was granted and assigned to CoDa Therapeutics on August, 2017 by the United States Patent and Trademark Office.	‌ CoDa Therapeutics	‌ CoDa Therapeutics	United States Patent and Trademark Office	9738892	August 22, 2017
‌ US Patent 8975237 Treatment of fibrotic conditions	Patent 8975237 was granted and assigned to CoDa Therapeutics on March, 2015 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	8975237	March 10, 2015
‌ US Patent 9035037 Medical devices	Patent 9035037 was granted and assigned to CoDa Therapeutics on May, 2015 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	9035037	May 19, 2015
‌ US Patent 9932592 Formulations comprising antisense nucleotides to connexins	Patent 9932592 was granted and assigned to CoDa Therapeutics on April, 2018 by the United States Patent and Trademark Office.	‌ CoDa Therapeutics	‌ CoDa Therapeutics	United States Patent and Trademark Office	9932592	April 3, 2018
‌ US Patent 9248141 Methods of treatment by administering anti-connexin proteins and mimetics	Patent 9248141 was granted and assigned to CoDa Therapeutics on February, 2016 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	9248141	February 2, 2016
‌ US Patent 9156896 Wound healing compositions and treatments	Patent 9156896 was granted and assigned to CoDa Therapeutics on October, 2015 by the United States Patent and Trademark Office.	‌ CoDa Therapeutics	‌ CoDa Therapeutics	United States Patent and Trademark Office	9156896	October 13, 2015
‌ US Patent 9193754 Formulations comprising antisense nucleotides to connexins	Patent 9193754 was granted and assigned to CoDa Therapeutics on November, 2015 by the United States Patent and Trademark Office.	‌ CoDa Therapeutics	‌ CoDa Therapeutics	United States Patent and Trademark Office	9193754	November 24, 2015
‌ US Patent 9637745 Impaired wound healing compositions and treatments	Patent 9637745 was granted and assigned to CoDa Therapeutics on May, 2017 by the United States Patent and Trademark Office.	‌ CoDa Therapeutics	‌ CoDa Therapeutics	United States Patent and Trademark Office	9637745	May 2, 2017
‌ US Patent 8034789 Antisense compounds targeted to connexins and methods of use thereof	Patent 8034789 was granted and assigned to CoDa Therapeutics on October, 2011 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	8034789	October 11, 2011
‌ US Patent 9457044 Methods and compositions for wound healing	Patent 9457044 was granted and assigned to CoDa Therapeutics on October, 2016 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	9457044	October 4, 2016
‌ US Patent 8685940 Impaired wound healing compositions and treatments	Patent 8685940 was granted and assigned to CoDa Therapeutics on April, 2014 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	8685940	April 1, 2014
‌ US Patent 8815819 Anti-connexin compounds targeted to connexins and methods of use thereof	Patent 8815819 was granted and assigned to CoDa Therapeutics on August, 2014 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	8815819	August 26, 2014
‌ US Patent 7902164 Formulations comprising antisense nucleotides to connexins	Patent 7902164 was granted and assigned to CoDa Therapeutics on March, 2011 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	7902164	March 8, 2011
‌ US Patent 8314074 Formulations comprising antisense nucleotides to connexins	Patent 8314074 was granted and assigned to CoDa Therapeutics on November, 2012 by the United States Patent and Trademark Office.		‌ CoDa Therapeutics	United States Patent and Trademark Office	8314074	November 20, 2012

21 results

0 selected

21 results

0 selected